5/18
Coronavirus Research
2022 Breakthrough Prize in Life Sciences awarded to mRNA pioneers Drew Weissman and Katalin Karikó
Weissman and Karikó are honored for engineering modified RNA technology which enabled rapid development of effective COVID-19 vaccines.
COVID-19 presents an understanding of nurses’ moral distress during crisis care
Researchers from the School of Nursing found that effective leadership and communication reduced moral distress for nurses providing patients with crisis care during the pandemic.
Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize
For their landmark research that set a foundation for the mRNA SARS-CoV-2 vaccines, Drew Weissman and Katalin Karikó have been selected to receive the prize after decades of work.
COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval
Pfizer/BioNTech’s vaccine to prevent COVID-19 uses fundamental modified mRNA technology created by Drew Weissman and Katalin Karikó at the Perelman School of Medicine.
Penn study details robust T-cell response to mRNA COVID-19 vaccines
The results underline the importance of a second dose and include implications for booster shots.
Engineers create faster and cheaper COVID-19 testing with pencil lead
A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite.
A COVID vaccine for kids
Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential.
The long view on COVID-19 vaccine safety and efficacy
Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines.
New microfluidic device delivers mRNA nanoparticles a hundred times faster
With a “liquid assembly line,” Penn researchers have produced mRNA-delivering-nanoparticles significantly faster than standard microfluidic technologies.
Trauma patients with COVID-19 face greater risk of complications and death
Penn Medicine research shows COVID-19-positive patients with traumatic injuries have six times higher risk of death and complication than patients without COVID.
In the News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →